Abstract
Recent genetic screens of fly mutants and molecular analysis have revealed that the Hippo pathway controls both cell proliferation and apoptosis. Also, the Hippo pathway is reported to play a critical role in regulating tumorigenesis and epithelial‐mesenchymal transition (EMT). Specifically, adaptor protein Sav1 is the key component of the Hippo pathway; however its pathophysiological role in human cancer cells remains largely unknown. In this study, we found that ectopic expression of Sav1 induces apoptosis in human cancer cells and inhibits their growth and survival. In contrast, inhibition of Sav1 expression by shRNA failed to promote the human cancer cell proliferation and EMT. Moreover, we found that transcriptional co‐activator YAP and TAZ, the effector proteins of the Hippo pathway, are phosphorylated in Sav1 knockdown cells by similar extent to control cells. Taken together, although Sav1 is an essential component of the Hippo pathway, our results raise the possibility of Sav1‐independent hippo pathway activation in human cancer cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.